Press release
Infant Formula Ingredients Market is Projected to Garner Significant Revenues by 2025
The infant formula ingredients market is estimated to be valued at USD 16.7 billion in 2019 and is projected to reach USD 25.5 billion by 2025, at a CAGR of 7.3% during the forecast period. The global infant formula ingredients industry is expected to grow due to high growth in the APAC region caused by increasing birth rate, the inability of mothers to lactate, more number of women joining workforce post-childbirth, and companies producing ingredients similar to human milk (such as human milk oligosaccharides). China is the largest player for infant formula ingredients in the global market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212823308
The prebiotics segment is projected to be the fastest-growing in the infant formula ingredients market during the forecast period.
Usage of prebiotic ingredients in infant nutrition aids infant to overcome infections by providing health benefits. These include resisting gastrointestinal problems, building immunity, supporting increased mineral absorption, and lowering the tendency to become obese. Prebiotic ingredients used in infant formula include fructooligosaccharides, galactooligosaccharides, lactulose, polydextrose, and inulin. Boost in sales for infant formulas in the years to come will directly increase demand for infant formula ingredients.
The protein hydrolysate segment is projected to record the fastest growth during the forecast period.
Babies who are intolerant to both cow’s milk and soy-based formulas are given protein hydrolysate infant formula ingredients. These ingredients are obtained either through plant-based or animal-based sources. Some of the protein hydrolyzed based infant formula products include Enfamil Gentlease and Similac Sensitive. Several infant formula ingredients manufacturers are involved in R & D, to come up with ingredients as per the consumers demand, increasing sales of infant formula ingredients in the coming years derived from protein hydrolysate and other sources in the coming years.
The liquid & semi-liquid segment is projected to record the fastest growth during the forecast period.
Oils & fats are the most widely used liquid and semi-liquid ingredients for manufacturing infant formula. The liquid & semi-liquid segment is expected to exhibit high growth prospects in Asia Pacific. In Japan, liquid infant formulas are preferred owing to their convenience in emergencies such as natural disasters that frequently occur in the country.
The growing-up formula (12 months & above) segment is projected to record the fastest growth during the forecast period.
The growing-up milk (12 months & above) contains calcium, vitamin D, and iron, and mostly serves as a part of a balanced diet for infants. Given during the transition phase from infant nutrition to family food, manufacturers offering infant formula for this particular age group are expected to witness high growth prospects, especially from Asia Pacific.
Asia Pacific is projected to be the fastest-growing during the forecast period.
Asia Pacific infant formula ingredients market is projected to be the fastest-growing during the forecast period. Countries such as China, Japan, and South Korea are expected to be key revenue generators during the next few years. The region has seen a rapid transformation in terms of urbanization. This has enabled women to join workforce post-delivery, making infant formula the only nearest substitute to breast milk for infants.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=212823308
This report includes a study of marketing and development strategies along with the product portfolios of leading companies in the sodium hypophosphite market. It consists of the profiles of leading companies such as AAK AB (Sweden), Fonterra Co-operative Group Limited (New Zealand), Carbery Food Ingredients Limited (Ireland), Royal Friesland Campina N.V. (Netherlands), Sachsenmilch Leppersdorf GmbH (Germany), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Arla Foods amba (Denmark), Chr. Hansen Holdings A/S (Denmark), Kerry Group plc (Ireland), Lactalis Ingredients (France), Glanbia plc (Ireland), and Vitablend Nederland B.V. (Netherlands).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infant Formula Ingredients Market is Projected to Garner Significant Revenues by 2025 here
News-ID: 2413845 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…